• Saturday,September 21,2024
ururembotoursandtravel.com
X

Current approved therapeutic strategies for IPF and LC treatment

$ 12.00

5 (693) In stock

Share

Inhibition of LPA-LPAR1 and VEGF-VEGFR2 signaling in IPF

Idiopathic pulmonary fibrosis-specific Bayesian network integrating extracellular vesicle proteome and clinical information

Giorgia GUAITOLI, Resident

A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials, BMC Pulmonary Medicine

A comprehensive comparison of the safety and efficacy of drugs in the treatment of idiopathic pulmonary fibrosis: a network meta-analysis based on randomized controlled trials, BMC Pulmonary Medicine

Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis

hucMSCs treatment prevents pulmonary fibrosis by reducing circANKRD42-YAP1-mediated mechanical stiffness

Federal Register :: Medicare and Medicaid Programs; CY 2020 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; and Home Infusion Therapy Requirements

Enrico CLINI, Professor in Respiratory Medicine

Stefania CERRI, Assistant Professor, MD, PhD

Cells, Free Full-Text

Frontiers Elucidating shared biomarkers in gastroesophageal reflux disease and idiopathic pulmonary fibrosis: insights into novel therapeutic targets and the role of angelicae sinensis radix